Items where Author is "Chang, Kian-Meng"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article | Proceeding
Number of items: 4.

Article

Kuan, Jew-Win and Chang, Kian-Meng and Chin, Lee Phan and Wong, Shu Ping and Lim, Soo Min and Toh, See Guan and Loh, Weng Khean (2021) Fluctuation of BCR-ABL1 qPCRIS level beyond 0.1%IS after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years. Medical Journal of Malaysia, 76 (3). pp. 414-416. ISSN 0300-5283

Kuan, Jew-Win and Chang, Kian-Meng and Loh, Weng Khean and Phan, Chin Lee and Wong, Shu Ping and Chai, Alvin Jung Mau and Yong, Kar Ying and Voon, Kit Kian and Lim, Soo Min and Toh, See Guan (2019) A randomized control trial comparing peginterferon-α-2a versus observation after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years: Interim analysis. The Malaysian Journal of Pathology, 41 (3). p. 319. ISSN 0126-8635

Kuan, Jew-Win and Chang, Kian-Meng and Lau, Ngee Siang and Visalachy, Purushothaman and Tan, Sen Mui and Ong, Tee Chuan and Su, Anselm-Ting (2011) The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. Indian journal of hematology & blood transfusion, 27 (3). pp. 136-145. ISSN 1473-0502

Proceeding

Kuan, Jew-Win and Chang, Kian-Meng and Loh, Weng Khean and Phan, Chin Lee and Wong, Shu Ping and Chai, Alvin Jung Mau and Yong, Kar Ying and Voon, Kit Kian and Lim, Soo Min and Toh, See Guan (2016) A randomized control trial comparing peginterferon-α-2a versus observation after stopping tyrosine kinase inhibitor in chronic myeloid leukemia with deep molecular response for at least two years. In: Malaysia Society of Haematology Scientific Meeting 2016.

This list was generated on Fri Apr 19 11:33:03 2024 +08.